- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Patent holdings for IPC class C12Q 1/6883
Total number of patents in this class: 7555
10-year publication summary
|
224
|
289
|
596
|
735
|
753
|
730
|
781
|
797
|
740
|
567
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4335 |
170 |
| The Regents of the University of California | 20087 |
133 |
| Natera, Inc. | 325 |
131 |
| The Board of Trustees of the Leland Stanford Junior University | 6462 |
96 |
| Cedars-Sinai Medical Center | 1165 |
78 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
69 |
| The Johns Hopkins University | 5714 |
66 |
| The Children's Hospital of Philadelphia | 794 |
58 |
| The General Hospital Corporation | 4771 |
55 |
| The Brigham and Women's Hospital, Inc. | 2214 |
51 |
| The Chinese University of Hong Kong | 151 |
47 |
| Centre National de La Recherche Scientifique | 10531 |
44 |
| President and Fellows of Harvard College | 5998 |
44 |
| The Broad Institute, Inc. | 1839 |
44 |
| Yale University | 2409 |
44 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2894 |
43 |
| Duke University | 3087 |
37 |
| Celera Corporation | 77 |
34 |
| bioMerieux | 927 |
33 |
| Assistance Publique-hopitaux de Paris (aphp) | 518 |
32 |
| Other owners | 6246 |